Vision Marine Technologies (VMAR) shares plunged 27% in recent Monday premarket activity after saying it signed securities purchase agreements with accredited and institutional investors to issue and sell units of its common shares for total gross proceeds of roughly $5.8 million.
Moderna (MRNA) shares dropped 19% after the company trimmed its 2025 revenue guidance to between $1.5 billion and $2.5 billion, down from its previous range of $2.5 billion to $3.5 billion.
Akoya Biosciences (AKYA) shares slipped 11% after Canaccord Genuity downgraded it to hold from buy with a $3.50 price target.
Cohu (COHU) stock was down almost 6% after Needham downgraded it to hold from buy.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。